Hospitals / providers

Ozempic and Eye Health: Balancing Metabolic Benefits with Vision Risks

An ADC Steps Into the First-Line Gap in Triple-Negative Breast Cancer

Alpha Radioligand Therapy Moves Prostate Cancer Into a New Infrastructure Test

AI Pathology Starts Moving Toward Treatment Selection

Ebola PHEIC Turns Outbreak Control Into a Preparedness Test

A New CELMoD Raises the Bar in Relapsed Myeloma
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
